Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Avandamet
Active Ingredients: Metformin hydrochloride 500mg
Rosiglitazone maleate 1.33mg equivalent to rosiglitazone free base 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: SB Pharmaco PR Inc, Barrio Certenejas, Cidra, Puerto Rico
Product: Avandamet
Active Ingredients: Metformin hydrochloride 500mg
Rosiglitazone maleate 2.65mg equivalent to rosiglitazone free base 2mg
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: SB Pharmaco PR Inc, Barrio Certenejas, Cidra, Puerto Rico
Product: Avandamet
Active Ingredients: Metformin hydrochloride 500mg
Rosiglitazone maleate 5.3mg equivalent to rosiglitazone free base 4mg
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: SB Pharmaco PR Inc, Barrio Certenejas, Cidra, Puerto Rico
Dated this 13th day of January 2005.
BARRY BORMAN, acting as Deputy Director-General, Public Health, for the period 5 January 2005 to 24 January 2005 (pursuant to delegation given by the Minister of Health on 6 July 2001).